 |
Immune globulin intravenous (human) |
|---|---|
| Trade Name | Immune Globulin Intravenous (Human) Immuno, Iveegam |
| Orphan Indication | Patients with acute myocarditis |
| USA Market Approval | USA |
| USA Designation Date | 1993-11-22 00:00:00 |
| Sponsor | Immuno Clinical Research Corp.;750 Lexington Avenue;New York, New York, 10022 |
